Gui Z - Search Results

1

Comprehensive pan-cancer analysis indicates UCHL5 as a novel cancer biomarker and promotes cervical cancer progression through the Wnt signaling pathway.

Bao L, Wu Y, Ren Z, Huang Y, Jiang Y, Li K, Xu X, Ye Y, Gui Z. Bao L, et al. Among authors: gui z. Biol Direct. 2024 Dec 19;19(1):139. doi: 10.1186/s13062-024-00588-6. Biol Direct. 2024. PMID: 39702250 Free PMC article.

2

Identification and validation of a novel anoikis-related long non-coding RNA signature for pancreatic adenocarcinoma to predict the prognosis and immune response.

Jiang Y, Ye Y, Huang Y, Wu Y, Wang G, Gui Z, Zhang M, Zhang M. Jiang Y, et al. Among authors: gui z. J Cancer Res Clin Oncol. 2023 Nov;149(16):15069-15083. doi: 10.1007/s00432-023-05285-x. Epub 2023 Aug 24. J Cancer Res Clin Oncol. 2023. PMID: 37620430

3

Construction of a novel cancer-associated fibroblast-related signature to predict clinical outcome and immune response in colon adenocarcinoma.

Zheng L, Zhang J, Ye Y, Shi Z, Huang Y, Zhang M, Gui Z, Li P, Qin H, Sun W, Zhang M. Zheng L, et al. Among authors: gui z. Aging (Albany NY). 2023 Sep 16;15(18):9521-9543. doi: 10.18632/aging.205032. Epub 2023 Sep 16. Aging (Albany NY). 2023. PMID: 37724904 Free PMC article.

4

Identification of a cancer associated fibroblasts-related index to predict prognosis and immune landscape in ovarian cancer.

Ye Y, Zhang S, Jiang Y, Huang Y, Wang G, Zhang M, Gui Z, Wu Y, Bian G, Li P, Zhang M. Ye Y, et al. Among authors: gui z. Sci Rep. 2023 Dec 7;13(1):21565. doi: 10.1038/s41598-023-48653-w. Sci Rep. 2023. PMID: 38057405 Free PMC article.

5

Construction of a novel cancer-associated fibroblast-related signature to predict clinical outcome and immune response in cervical cancer.

Gui Z, Ye Y, Li Y, Ren Z, Wei N, Liu L, Wang H, Zhang M. Gui Z, et al. Transl Oncol. 2024 Aug;46:102001. doi: 10.1016/j.tranon.2024.102001. Epub 2024 Jun 7. Transl Oncol. 2024. PMID: 38850798 Free PMC article.

6

Tumor-infiltrating B cell-related lncRNA crosstalk reveals clinical outcomes and tumor immune microenvironment in ovarian cancer based on single-cell and bulk RNA-sequencing.

Huang Y, Gui Z, Wu M, Zhang M, Jiang Y, Ding Q, Yang J, Ye Y, Zhang M. Huang Y, et al. Among authors: gui z. Heliyon. 2024 Oct 18;10(21):e39496. doi: 10.1016/j.heliyon.2024.e39496. eCollection 2024 Nov 15. Heliyon. 2024. PMID: 39559246 Free PMC article.

7

Zhao Q, Ye Y, Zhang Q, Wu Y, Wang G, Gui Z, Zhang M. Zhao Q, et al. Among authors: gui z. Biochem Biophys Rep. 2023 Dec 7;37:101600. doi: 10.1016/j.bbrep.2023.101600. eCollection 2024 Mar. Biochem Biophys Rep. 2023. PMID: 38371527 Free PMC article.

8

Knowledge mapping of early-onset colorectal cancer from 2000 to 2022: A bibliometric analysis.

Zhang M, Zhu S, Chen L, Wu Y, Ye Y, Wang G, Gui Z, Zhang C, Zhang M. Zhang M, et al. Among authors: gui z. Heliyon. 2023 Jul 21;9(8):e18499. doi: 10.1016/j.heliyon.2023.e18499. eCollection 2023 Aug. Heliyon. 2023. PMID: 37560685 Free PMC article.

9

STUB1 is acetylated by KAT5 and alleviates myocardial ischemia-reperfusion injury through LATS2-YAP-β-catenin axis.

Liu C, Gui Z, An C, Sun F, Gao X, Ge S. Liu C, et al. Among authors: gui z. Commun Biol. 2024 Apr 1;7(1):396. doi: 10.1038/s42003-024-06086-9. Commun Biol. 2024. PMID: 38561411 Free PMC article.

10

Esophageal stenosis as an independent factor of poor prognosis in patients with ESCC treated with definitive chemoradiotherapy.

Gui Z, Hu W, Kong Q, Liu C, Xu Y, Wang F. Gui Z, et al. Future Oncol. 2022 Dec;18(38):4193-4207. doi: 10.2217/fon-2022-0125. Epub 2023 Jan 18. Future Oncol. 2022. PMID: 36651337

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

472 results

Search Page

Filters